Wedge Capital Management L L P NC Has $1.28 Million Stock Holdings in Encompass Health Corporation $EHC

Key Points

• Wedge Capital Management L L P NC significantly reduced its holdings in Encompass Health Corporation by 82% in the 2nd quarter, now owning 10,437 shares valued at approximately $1.28 million.
• Institutional investors collectively hold 97.25% of Encompass Health's stock, showing a trend of increased investment, with several firms growing their stakes in the company.
• Encompass Health announced a quarterly dividend increase from $0.17 to $0.19 per share, reflecting the company's solid financial performance and commitment to returning value to shareholders.

Wedge Capital Management L L P NC decreased its position in Encompass Health Corporation (NYSE:EHC - Free Report) by 82.0% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,437 shares of the company's stock after selling 47,460 shares during the quarter. Wedge Capital Management L L P NC's holdings in Encompass Health were worth $1,280,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the company. Pinnacle Wealth Planning Services Inc. grew its stake in shares of Encompass Health by 4.0% in the 1st quarter. Pinnacle Wealth Planning Services Inc. now owns 2,597 shares of the company's stock worth $263,000 after acquiring an additional 99 shares in the last quarter. Caitong International Asset Management Co. Ltd grew its stake in shares of Encompass Health by 19.0% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company's stock worth $73,000 after acquiring an additional 115 shares in the last quarter. UMB Bank n.a. grew its stake in shares of Encompass Health by 10.9% in the 2nd quarter. UMB Bank n.a. now owns 1,187 shares of the company's stock worth $146,000 after acquiring an additional 117 shares in the last quarter. Arlington Trust Co LLC grew its stake in shares of Encompass Health by 22.9% in the 1st quarter. Arlington Trust Co LLC now owns 671 shares of the company's stock worth $68,000 after acquiring an additional 125 shares in the last quarter. Finally, Exchange Traded Concepts LLC grew its stake in shares of Encompass Health by 1.9% in the 2nd quarter. Exchange Traded Concepts LLC now owns 8,095 shares of the company's stock worth $993,000 after acquiring an additional 152 shares in the last quarter. Institutional investors own 97.25% of the company's stock.

Analyst Ratings Changes

Several analysts have recently issued reports on EHC shares. Wall Street Zen lowered shares of Encompass Health from a "strong-buy" rating to a "buy" rating in a research note on Friday, June 6th. UBS Group increased their price target on shares of Encompass Health from $130.00 to $140.00 and gave the company a "buy" rating in a research report on Wednesday, August 6th. Bank of America increased their price target on shares of Encompass Health from $145.00 to $160.00 and gave the company a "buy" rating in a research report on Wednesday, September 10th. KeyCorp increased their price target on shares of Encompass Health from $135.00 to $140.00 and gave the company an "overweight" rating in a research report on Tuesday, September 16th. Finally, Truist Financial increased their price target on shares of Encompass Health from $135.00 to $140.00 and gave the company a "buy" rating in a research report on Thursday, August 14th. One research analyst has rated the stock with a Strong Buy rating and seven have given a Buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Buy" and an average price target of $138.43.

Encompass Health Trading Up 1.7%

Shares of EHC opened at $126.12 on Tuesday. The firm's 50 day simple moving average is $118.25 and its 200 day simple moving average is $113.99. The company has a market capitalization of $12.70 billion, a P/E ratio of 24.68, a P/E/G ratio of 2.17 and a beta of 0.92. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.06 and a quick ratio of 1.06. Encompass Health Corporation has a 1-year low of $87.85 and a 1-year high of $127.15.

Encompass Health (NYSE:EHC - Get Free Report) last announced its earnings results on Monday, August 4th. The company reported $1.40 earnings per share for the quarter, beating analysts' consensus estimates of $1.20 by $0.20. The business had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.43 billion. Encompass Health had a net margin of 9.22% and a return on equity of 17.83%. Encompass Health's quarterly revenue was up 12.0% on a year-over-year basis. During the same period last year, the firm posted $1.11 earnings per share. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. Sell-side analysts forecast that Encompass Health Corporation will post 4.8 earnings per share for the current fiscal year.

Encompass Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be paid a $0.19 dividend. This is an increase from Encompass Health's previous quarterly dividend of $0.17. This represents a $0.76 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend is Wednesday, October 1st. Encompass Health's payout ratio is 13.31%.

Insiders Place Their Bets

In related news, EVP Patrick William Tuer sold 1,020 shares of the firm's stock in a transaction that occurred on Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total value of $126,061.80. Following the sale, the executive vice president directly owned 18,846 shares of the company's stock, valued at $2,329,177.14. This trade represents a 5.13% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 2.10% of the stock is owned by corporate insiders.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Corporation (NYSE:EHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.